Clinical Research Details

Descriptive Information
Excellent intubating conditions with remifentanil-propofol and either low-dose rocuronium or succinylcholine

Sahar Sayyid
ss01@aub.edu.lb

19440810
Completed

Clinical Research - Clinical Trials (phase 0, 1,2 3 & 4)  


No
Collaborators
  • Samar Taha
  • Ghassan Kanazi
  • Mohammad el Khatib
  • Anis Baraka
  • Marie Aouad Maroun
Coordinators
Fadia Shebbo
fs97@aub.edu.lb
Extension: 5411
Conditions and Keywords
intubating conditions
intubation;remifentanil–propofol;rocuronium;succinylcholine
Study Design
Eligibility and IRB
Both
Min:
Max:
Yes
No







patients who were ASA physical status I to II, aged 18–60 years, and scheduled for elective orthopedic, gynecologic, and otorhinolaryngological ambulatory surgery

a history of gastroesophageal reflux, hypertension, asthma, drug or alcohol abuse, cardiovascular disease, body mass index >30 kg · m−2, neuromuscular disease or medication influencing neuromuscular transmission, and anticipated difficult intubation. Also excluded were patients with a contraindication to the use of succinylcholine, such as predisposition to malignant hyperthermia, decreased pseudocholinesterase activity or known genetic variation, and conditions causing susceptibility to succinylcholine-induced hyperkalemia (for example burn or denervation injury).